For USA & Canada visitors: therogenx.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?
Yes, Please Proceed
About
Medical Products
Allografts
International Research
Quality Controls
Contact

Quality Controls

Quality Controls

Quality, Compliance & Processing Standards

TheroGenX is committed to maintaining rigorous standards of quality, safety, and process control across all human tissue allograft materials.

Regulatory Alignment (U.S. & International)
TheroGenX operates in alignment with:

  • U.S. Food and Drug Administration (FDA) regulations
  • 21 CFR Part 1271 for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
  • Current Good Tissue Practices (cGTP)
  • International regulatory expectations for human tissue products

Our systems are structured to support compliance with both U.S. regulatory frameworks and international market requirements.

Good Manufacturing & Tissue Practices

TheroGenX follows industry-recognized standards for biologic processing:

  • cGTP-compliant processes under FDA guidelines
  • Environmental controls consistent with tissue processing standards
  • GMP-aligned environments for controlled biologic handling
  • Aseptic processing techniques
  • Controlled and monitored production conditions
  • Defined and controlled workflows across sourcing, processing, and packaging
  • Processed in accordance with applicable requirements under 21 CFR Part 1271.

These systems are designed to support product integrity, safety, and consistency across all batches.

Donor Screening & Tissue Qualification

All biologic materials are managed through defined qualification protocols:

  • Comprehensive donor screening and medical review
  • Infectious disease testing in accordance with regulatory standards
  • Full traceability from donor to final product
  • Controlled chain-of-custody procedures

Quality Control & Product Testing

Multi-level quality control systems designed to support defined specifications:

  • Structural and visual evaluation
  • Lot-to-lot consistency verification
  • Environmental monitoring
  • Sterility and bioburden testing (as applicable)
  • Stability and storage validation

Traceability & Documentation

TheroGenX maintains a fully integrated tracking system providing:

  • End-to-end traceability
  • Lot identification and batch tracking
  • Audit-ready documentation
  • Regulatory transparency for partners

Storage, Handling & Distribution

All materials are managed under validated conditions:

  • Controlled temperature storage environments
  • Temperature-monitored logistics
  • Protective packaging systems
  • Chain-of-custody tracking

    Pipeline

    About

    News

    Research

    About

    International Research

    Allografts